window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

clinical trial

  • Central Nervous System,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme

    CNS Pharmaceuticals has reported the primary analysis of its clinical [...]

    November 25, 2025
  • Biomanufacturing,Cell & Gene Therapy,Clinical Development,Rare Diseases,Regulatory Affairs

    Imlifidase enables gene therapy for Crigler–Najjar patients with AAV immunity

    Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

    October 12, 2025
  • Biotech,Clinical studies,Oncology,Pharmaceuticals and therapeutics

    Kairos Pharma to present Phase 2 prostate cancer data at ESMO 2025

    Kairos Pharma, Ltd. will present positive safety and early efficacy [...]

    October 8, 2025
  • Clinical Development,Clinical Trials,Obesity,Pharmaceuticals and therapeutics,Research & Development

    Skye Bioscience Phase 2a data show added weight loss with nimacimab–semaglutide combination

    Skye Bioscience has reported topline results from its Phase 2a [...]

    October 7, 2025
  • Chronic diseases,Clinical Development,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    Amorphical reports positive interim results from ongoing Crohn’s disease trial

    Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]

    October 1, 2025
  • Cell & Gene Therapy,Central Nervous System,Clinical Trials,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Gene therapy AMT-130 slows Huntington’s disease progression in early trial

    A gene therapy developed by uniQure appears to slow progression [...]

    September 25, 2025
  • Cell & Gene Therapy,Clinical Trials,Pharmaceuticals and therapeutics

    CellProthera publishes Phase 1/2b results of stem cell therapy for post-heart attack patients

    CellProthera has published peer-reviewed results from its phase 1/2b Excellent [...]

    September 14, 2025
  • Clinical Development,Clinical Trials,Precision medicine

    BiomX’s BX004 slashes antibiotic-resistant bacteria in landmark cystic fibrosis study

    Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]

    July 16, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding

    Ethris signs strategic collaboration with Thermo Fisher Scientific to provide access to mRNA technology platforms

    Partnership further validates Ethris’ novel technology platform based on stabilized [...]

    June 16, 2025
  • Cell & Gene Therapy,Clinical Trials

    AstriVax begins clinical trial of targeted T-cell immunotherapy for hepatitis B

    AstriVax Therapeutics has initiated a phase 1 clinical trial of [...]

    June 24, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top